Related Experiment Video
Updated: Mar 9, 2026

A Familial Hypercholesterolemia Human Liver Chimeric Mouse Model Using Induced Pluripotent Stem Cell-derived Hepatocytes
Published on: September 15, 2018
A Web-Based Registry for Familial Hypercholesterolaemia
Kathryn R Napier1, Jing Pang2, Leanne Lamont3
1Centre for Comparative Genomics, Murdoch University, Perth, WA, Australia.
Insights
Familial hypercholesterolaemia (FH), a genetic disorder causing early heart disease, often goes undiagnosed and undertreated. The FH Australasia Network Registry improves care through standardized data collection for better patient outcomes.
Area of Science:
- Cardiovascular Medicine
- Genetics
- Public Health
Background:
- Familial hypercholesterolaemia (FH) is a prevalent and severe monogenic disorder of lipoprotein metabolism.
- It significantly increases the risk of premature coronary heart disease.
- Many FH patients are currently under-treated and remain undiagnosed, highlighting a critical gap in care.
Purpose of the Study:
- To introduce the FH Australasia Network Registry as a key element in a comprehensive care model for FH.
- To establish a standardized, high-quality, and cost-effective system for FH care in the Australasia-Pacific region.
- To improve patient outcomes through enhanced management of FH.
Main Methods:
- The FH Australasia Network Registry was developed using an open-source, interoperable registry framework.
- This framework allows for efficient customization and dynamic modification of web-based disease registries.
- The registry facilitates the collation of data for various clinical and research purposes.
Main Results:
- The registry provides a standardized system for FH care across the Australasia-Pacific region.
- It enables efficient data collection and management for FH patients.
- The system is adaptable to evolving registry requirements.
Conclusions:
- The FH Australasia Network Registry is essential for improving health services for FH patients.
- It supports clinical service planning, clinical trials, and audits.
- The registry will inform clinical best practices and enhance patient care for familial hypercholesterolaemia.
Abstract:
Familial hypercholesterolaemia (FH) is the most common and serious monogenic disorder of lipoprotein metabolism that leads to premature coronary heart disease. Patients with FH are often under-treated, and many remain undiagnosed. The deployment of the FH Australasia Network Registry is a crucial component of the comprehensive model of care for FH, which aims to provide a standardised, high-quality and cost-effective system of care that is likely to have the highest impact on patient outcomes. The FH Australasia Network Registry was customised using a registry framework that is an open source, interoperable system that enables the efficient customisation and deployment of national and international web-based disease registries that can be modified dynamically as registry requirements evolve. The FH Australasia Network Registry can be employed to improve health services for FH patients across the Australasia-Pacific region, through the collation of data to facilitate clinical service planning, clinical trials, clinical audits, and to inform clinical best practice.
Related Concept Videos
Cholesterol: Significance and Regulation
Considering cholesterol and...
Blood Studies for Cardiovascular System III: Serum Lipid Profile
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Atherosclerosis III: Management
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Lipid Catabolism

